DAX24.330 +1,6%Est505.854 +0,4%MSCI World4.343 -0,1%Top 10 Crypto9,7300 -3,2%Nas26.092 -0,5%Bitcoin65.545 -1,8%Euro1,1640 +0,1%Öl110,0 +0,5%Gold4.537 -0,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 Infineon 623100 Siemens Energy ENER6Y SAP 716460 Deutsche Telekom 555750 NEL ASA A0B733 Lufthansa 823212 Microsoft 870747 Allianz 840400 Micron Technology 869020 Alphabet A (ex Google) A14Y6F RENK RENK73 Münchener Rückversicherungs-Gesellschaft 843002 Amazon 906866
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Trump droht Iran mit Zerstörung: DAX dreht ins Plus -- Wall Street uneins -- Berkshire Hathaway setzt im ersten Quartal auf Alphabet -- Siemens Energy, Rheinmetall, DroneShield, NEL im Fokus
Top News
DroneShield-Aktie fällt dennoch: ASX lockert Berichtspflichten nach Cashflow-Erfolg DroneShield-Aktie fällt dennoch: ASX lockert Berichtspflichten nach Cashflow-Erfolg
Dominion Energy-Aktie springt 10 Prozent hoch: Mega-Fusion mit NextEra Dominion Energy-Aktie springt 10 Prozent hoch: Mega-Fusion mit NextEra
Suche...
Jetzt kostenlos
bei finanzen.net anmelden
Watchlists & Musterdepots Tools & integriertes Trading Newsletter, Trading-Desk uvm.
Schon einen Account? Anmelden
Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Pacific Biosciences of California Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
1,00 EUR +0,04 EUR +4,36 %
STU
1,16 USD +0,04 USD +3,13 %
BTT
finanzen.net zero
Pacific Biosciences of California jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.298,96 Mio. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1C3EQ

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS69404D1081

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPACB

Pacific Biosciences of California Aktien News

DatumMeistgelesen
PR NewswireAthena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
PR NewswireTarget ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to Date
PR NewswireVolta Labs joins PacBio Compatible program to help PacBio customers scale sequencing through automated library prep
Wer­bungPacific Biosciences of California-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswirePacBio and International Research Consortium CoLoRS Announce Release of First-Ever HiFi Long-Read Variant Database
PR NewswireAmbry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare Diseases
PR NewswirePacBio Announces First Quarter 2024 Financial Results
PR NewswirePacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue Guidance
PR NewswireEstonia National Biobank Selects PacBio to Sequence 10,000 Whole Genomes
PR NewswirePacBio Grants Equity Incentive Award to New Employee
PR NewswirePacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research Solutions
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results
PR NewswirePacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale
PR NewswirePacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024
PR NewswirePacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
PR NewswirePacBio Announces Record Preliminary Fourth Quarter and Full Year Revenue Growing 113% and 56%, respectively
PR NewswirePacBio to Present at 42nd Annual J.P. Morgan Healthcare Conference
PR NewswirePacBio Announces the Retirement of David Botstein, Ph.D., from its Board of Directors
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio Announces HiFi Solves, a Global Consortium of Clinical Genomics Research Leaders
PR NewswirePacBio Enables Rare and Inherited Disease Research by Adding Tertiary Analysis Partners to PacBio Compatible
PR NewswirePacBio Announces Kinnex RNA Kits, Further Scaling HiFi Sequencing in Full-Length RNA, Single-Cell RNA and 16S rRNA Applications
PR NewswirePacBio Announces Third Quarter 2023 Financial Results
PR NewswirePacBio Announces Appointment of David Meline to Board of Directors
PR NewswirePacBio to Report Third Quarter 2023 Financial Results on October 30, 2023
PR NewswirePacBio Announces Complete Computational Workflow for Human Whole Genome Sequencing Data Analysis
PR NewswirePacBio Announces PacBio Capital
PR NewswirePacBio Announces Collaboration with Leading Library Preparation Automation Partners
PR NewswirePacBio to Present at Upcoming Investor Conferences
PR NewswirePacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care
PR NewswirePacBio Reports Equity Incentive Awards to New Employees Under Nasdaq Listing Rule 5635(c)(4)
PR NewswirePacBio Announces Second Quarter 2023 Financial Results
PR NewswirePacBio Enters into Agreement to Acquire Apton Biosystems to Accelerate the Development of a Next Generation, High Throughput, Short-read Sequencer
PR NewswirePacBio Begins Commercialization of the Onso Short-Read Sequencing System
PR NewswirePacBio to Report Second Quarter 2023 Financial Results on August 2, 2023
PR NewswirePacBio's Revio System Empowers Bioscientia to Scale Long-Read Whole Genome Sequencing and Unravel the Mysteries of Rare Disease
PR NewswirePacBio and Radboud University Medical Center Team Up for New Discoveries in Rare Disease Research
PR NewswirePacBio Announces the Appointment of Olga Troyanskaya from Princeton University to the Scientific Advisory Board
PR NewswirePacBio to Present at Upcoming Investor Conferences

Pacific Biosciences of California News

Pacific Biosciences of California News: auf dieser Seite finden Sie alle Pacific Biosciences of California News und Nachrichten zur Pacific Biosciences of California Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Pacific Biosciences of California News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Pacific Biosciences of California News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.